AZD6738, Ceralasertib
D5339C00001
Phase 2 small_molecule active
Quick answer
AZD6738, Ceralasertib for Advanced Cancer Whose Tumours Contain Molecular Alterations is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Advanced Cancer Whose Tumours Contain Molecular Alterations
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active